The design, synthesis, and conformational analysis of an oligobenzanilide helix mimetic scaffold capable of simultaneous mimicry of two faces of an α-helix is reported. The synthetic methodology provides access to diverse monomer building blocks amenable to solid-phase assembly in just four synthetic steps. The conformational flexibility of model dimers was investigated using a combination of solid and solution state methodologies supplemented with DFT calculations. The lack of noncovalent constraints allows for significant conformational plasticity in the scaffold, thus permitting it to successfully mimic residues i, i+2, i+4, i+6, i+7, and i+9 of a canonical α-helix.
The design, synthesis, and conformational analysis of an oligobenzanilide helix mimetic scaffold capable of simultaneous mimicry of two faces of an α-helix is reported. The synthetic methodology provides access to diverse monomer building blocks amenable to solid-phase assembly in just four synthetic steps. The conformational flexibility of model dimers was investigated using a combination of solid and solution state methodologies supplemented with DFT calculations. The lack of noncovalent constraints allows for significant conformational plasticity in the scaffold, thus permitting it to successfully mimic residues i, i+2, i+4, i+6, i+7, and i+9 of a canonical α-helix.
Protein–protein interactions
(PPIs) are central to all biological processes and offer a vast array
of potential therapeutic targets.[1−3] However, selective targeting
of protein–protein interfaces remains an enormous challenge.
In comparison to the small, well-defined pocket of an enzyme–substrate
interaction (300–500 Å2), the interface of
a typical PPI is large (1000–2000 Å2) and topographically
featureless.[4,5] The most common molecular recognition
scaffold in multiprotein complexes is the α-helix, and as such,
numerous strategies to target this class of PPI using rationally designed
molecules have been reported, including both peptidic and nonpeptidic
approaches, a concept known as peptidomimetics.[6,7]Typically, helix mimetics possess two common features: a rigid
scaffold to mimic the rod-like morphology of the helical backbone
and side chains to recapitulate the spatial orientation of hotspot
residues on the native helix.[8] The majority
of scaffolds reported have focused on mimicry of key recognition residues
located on a single face of an α-helix (i, i+3/4, and i+7).However, given that
roughly one-third of PPIs interact through
more than one helical face, there is an obvious requirement for helix
mimetics that simultaneously mimic more than one helical face.[9] Embellishment of previously reported scaffolds
has resulted in multifacial helix mimetics such as bis- andtris-benzamides, and benzoylureas and novel
scaffolds such as diphenylacetylenes and azaoctanes have also been
developed (Figure ).[10−15]
Figure 1
Previously
published multifacial α-helix mimetics: bis-benzamides, benzoylureas, diphenylacetylenes, azaoctanes,
and our novel oligobenzanilide.
Previously
published multifacial α-helix mimetics: bis-benzamides, benzoylureas, diphenylacetylenes, azaoctanes,
and our novel oligobenzanilide.Common to all two-faced helix mimetics published are lengthy,
complex
syntheses that limit their potential as generic tools for PPI inhibition.
As part of our interest in developing methods to inhibit complex protein–protein
interactions, we sought to design a novel synthetically accessible
two-faced α-helix mimetic scaffold. Given the prevalence of
oligobenzamide scaffolds, we chose to develop a two-faced scaffold
based upon this linkage. Herein, we describe the design, synthesis,
and conformational analysis of a novel 3-O-alkyated,
4-N-dialkylated helix mimetic that is capable of
simultaneously mimicking residues i, i+2, i+4, i+6, i+7, and i+9 of a canonical α-helix.Our novel scaffold was designed by combining two previously published
scaffolds onto a single helix mimetic: Wilson’s N-alkylated triarylamide and Boger’s 3-O-alkylated
triarylamide were combined to give a 3-O-,4-N-dialkylated scaffold capable of simultaneous mimicry of
two helical faces (Figure ).[16,17] The synthetic route to the individual
monomers is shown in Scheme . Notable features of the synthetic route are (i) a common
starting material to access most monomers, (ii) compatibility with
the Fmoc/Bu protocol for solid-phase
synthesis (SPS), and (iii) the wide variety of functionality, both
natural and unnatural, that may be incorporated at both positions
on the individual monomers.
Scheme 1
Synthesis of Fmoc-Protected Monomers
3-Fluoro-4-nitrobenzoic acid
was used as the starting material
for monomer synthesis. The nitro group simultaneously activates the
3′-position for nucleophilic aromatic substitution and “protects”
the aniline required for installation of the second side chain and
subsequent coupling reactions. Using this SNAr approach,
it is possible to incorporate functionality found across the majority
of proteinogenic amino acids as well as the enormous chemical space
that has not been sampled by nature. For most monomers, catalytic
hydrogenation afforded the primary aniline in near quantitative yields.
For monomers with functionality susceptible to hydrogenation, a tin(II)
chloride-based reduction was used. The second side chain was introduced
onto the primary aniline through a one-pot reductive amination using
a picoline–borane complex (pic-BH3) as the stoichiometric
reductant. All aldehydes corresponding to hydrophobic amino acids
side chains are commercially available. Unoptimized yields for these
hydrophobic aldehydes were typically >80%. Aldehydes for installation
of polar side chains were typically obtained by oxidation of the hydroxycarbamate
to the aldehyde with Dess–Martin periodinane.To render
the monomers compatible with Fmoc/Bu
SPS, the secondary anilines were Fmoc protected to afford
the tertiary amide in reasonable yields (40–70%). Using this
four-step protocol, we generated a library of 13 diverse monomers
containing charged, polar, and hydrophobic functionality in both positions
(Table and Figure S1).
Table 1
3-O, 4-N-Dialkylated Monomers Synthesized
In comparison to previously
published helix mimetics, oligomers
were assembled by loading the monomers directly onto a solid support
(Scheme ). HATU mediated
coupling under microwave heating allowed the Fmoc-protected monomers
to be loaded onto a rink amide resin, whereas monomers could be loaded
on a 2-chlorotrityl resin at room temperature by stirring with DIPEA.
To effect amide bond formation, the benzoic acid was activated in situ to the acyl chloride using Ghosez’s reagent
in anhydrous N-methyl-2-pyrollidone (NMP) according
to previously published methodology (Scheme ).[18] Products
were isolated by mass-directed purifications. To exemplify the methodology,
three dimers and two trimers were successfully produced bearing a
range of hydrophobic and polar side chains (Figures and S2 and Table ).
Scheme 2
Monomer Resin Loading
Scheme 3
Solid Phase Oligomer
Synthesis
Figure 2
3-O,
4-N-Dialkylated benzanilide
dimers synthesized and the conformational and stereochemical isomerization
available to the helix mimetic scaffold.
Table 2
3-O, 4-N-Dialkylated Benzanilide Dimers and Trimers
Synthesized
3-O,
4-N-Dialkylated benzanilide
dimers synthesized and the conformational and stereochemical isomerization
available to the helix mimetic scaffold.It is well established that N-alkylated
benzanilides
preferentially adopt a “folded” conformation about the
amide bond in which the aryl rings are cis (formally E/s-trans).[19−21]Clearly, a permanent cis relationship
about the
amide bond is not representative of the elongated structure of the
α-helix and as such is unlikely to lead to effective perturbation
of α-helix-mediated PPIs. However, the N-alkylated
benzanilide scaffolds have been shown to be as potent as both (i)
the native peptide and (ii) benzamide scaffolds with preorganization
endowed through intramolecularhydrogen bonding networks.[16]To study the conformational space of our
scaffold, we selected
a triage of ab initio, solution-, and solid-state
techniques. For ease of analysis, representative dimers 14–16 were chosen as model compounds for experimental
studies. These dimers (Figure ) contain all the features common to more extended oligomers:
(i) a central amide linkage and thus the potential for cis–trans isomers, (ii) the potential for syn/anti conformers
with regards to the O-alkoxy substituent, and (iii)
the potential for restricted rotation about the aryl-nitrogen (Ar–N)
bond.Single crystals suitable for X-ray diffraction of compound 16 were generated by slow evaporation of a solution of hexane:ethyl
acetate (1:1). The unit cell contained two chemically identical but
crystallographically independent structures (Figure ). As expected, both structures clearly demonstrate
the cis-isomer about the amide bond with the two
3-O-substituents on opposing faces, presumably minimizing
unfavorable steric clashes. A[1,3] strain between phenyl
rings results in the aromatic rings lying roughly perpendicular to
the plane of the amide bond with the aromatic rings partially facing
each other. This perpendicular cis-anti conformer
is consistent with previous solid-state structures of tertiary benzanilides.[22] Interestingly, the amide bond displays a significant
distortion from planarity (12.1° for 16-A, 16.3° for 16-B, Table S1) placing the latter within the top 5% of the acyclic amides in which
the amide bond is not constrained with a ring (nonlactam).
Figure 3
X-ray structures
of 16 (16-Sa and 16-Ra).
X-ray structures
of 16 (16-Sa and 16-Ra).An important feature
highlighted by the solid-state structure is
the presence of axial chirality. Restricted rotation about the Ar–N
axis of benzanilides is long known, and many ortho-substituted anilides displaying axial chirality have been documented.[22−25] This bond rotation in helix mimetics is significant in allowing
scope for side chains to recapitulate native interactions through
an induced-fit binding mechanism. In multifacial helix mimetics, rotation
about the Ar–N bond corresponds to interconversion between
helical faces (Figure ).To calculate the barrier to rotation about the Ar–N
bond,
variable temperature (VT) NMR spectroscopy was used. Given rotation
about the Ar–N bond of unsymmetrically substituted anilides
interconverts not only enantiomeric conformers but diastereotopic
protons, it is possible to measure the rate of, and therefore barrier
to, rotation. The 1H NMR spectra of 14–16 at 298 K in DMSO-d6 all displayed
a single set of broadened resonances indicative of an exchange process
but with no distinction between the putative diastereotopic protons
(Figure S3). This is indicative of “fast”
exchange in solution at room temperature.To investigate the
nature of the exchange, low temperature NMR
spectra were taken at the slow-exchange limit. As expected, equal
intensity signal doubling due to restricted rotation about the Ar–N
axis was observed. For dimers 14, 15, and 16, anisochronicity was observed for all methylene protons
on the 3-O-alkoxy and amide substituents (spin-systems: 14 = AB; 15 = ABX3; 16 = varies). In addition, dimer 3 demonstrated diastereotopic
methyl doublets (spin-system = AX3X3′).
For all dimers studied, no magnetic inequivalence was observed for
protons on the secondary aniline substituent due to the increased
distance from the chiral Ar–N axis.Modeling the coalescence
of the methylene protons in dimer 14 gave a barrier to
rotation of 14.9 kcal mol–1 ± 0.59. For dimer 16, modeling the coalescence
of the methyl doublets gave a barrier to rotation of 13.9 kcal mol–1 ± 0.41 (Figures , S4, and S5). Both values
correspond to an estimated millisecond half-life for racemization.
Thus, although interconversion between enantiomers is slow on the
NMR time scale, the helix mimetic scaffold is not atropisomeric at
room temperature (Oki’s definition >1000 s at 25 °C[26]), and as such, the “helical” faces
mimicked by the scaffold are interconverting rapidly at 298 K and
thus sample a vast array of conformational space. Unfortunately, spectral
crowding prevented us from obtaining accurate energies for Ar–N
bond rotation for compound 15.
Figure 4
Experimental and simulated
NMR spectrum of 16 at the
slow-exchange limit.
Experimental and simulated
NMR spectrum of 16 at the
slow-exchange limit.2D NOESY and selNOE experiments at 298 K revealed through-space
correlations characteristic of a cis conformation
about the central amide bond (Figure S6), in line with a fast exchange at room temperature and existence
of cis conformations. However, no characteristic
correlation showing existence of a trans conformation
was observed by 2D NMR spectroscopy, presumably due to the large distance
(>5 Å) between the two aromatic moieties of interest in the trans conformation.To further explore the barriers
to rotation about the Ar–N
and amide bonds, DFT calculations were carried out, and energy barriers
of the rotations about the amide, Ar–C(O) and Ar–N bonds
were calculated based on methods previously used by Miller[27] (details in Supporting Information). A simplified model dimer was used in which all alkyl groups were
replaced by methyl groups (I, Figure ). Rotations solely about the amide bond
were found to have energy barriers as low as ΔG298 = 14.1 kcal/mol (I-TS2, Figures , S12, and S15) and only led to cis/trans conformational exchanges (i.e., no anti/syn conformational exchange, Figures S12 and S15). Interestingly, as previously reported by others,[27−29] concerted amide and Ar–N bond rotations occurred with slightly
lower energy barriers of ΔG298 =
12.1 kcal/mol (I-TS1, Figures , S10, and S19) and led to concerted cis/anti and syn/trans conformational exchanges
(i.e. anti/cis ↔ syn/trans or syn/cis ↔ anti/trans, Figures S10 and S19). These concerted
rotations are a consequence of the amide carbonyl oxygen and the ortho-O-alkoxy group of the benzamide “pushing”
each other during the rotations (Figure ). Rotations about the Ar–C(O) bond
were found to occur with low energy barriers ΔG298 < 10 kcal/mol for both trans and cis conformations about the amide bond (Figures S21 and S22). Finally, rotations about the Ar–N
bond in a cis conformation were found to have the
highest energy barrier ΔG298 = 16.7
kcal/mol due to a steric clash between the ortho-O-alkoxy group of the benzamide and the N-Me group of the amide moiety (III-TS5, Figure ).
Figure 5
Examples of energy barriers
ΔG298 for selected bond rotations
(see details in the Supporting Information)
Examples of energy barriers
ΔG298 for selected bond rotations
(see details in the Supporting Information)Numerous pathways are possible
for the exchange between the two
crystallographically observed enantiomers. However, exchange between
the two enantiomers via constant cis conformations
is likely to be the least favorable pathway due to the high energy
barrier of the Ar–N bond rotation (Figure ). Alternatively, pathways via extended conformations
are more favorable, involving bond rotations with lower energy barriers
with a maximum of 14.1 kcal/mol (Figure S30), in good agreement with the experimental values of 14.9 and 13.9
kcal/mol.The Boltzmann population of both conformers was calculated
based
on the energy required for rotation about the amide bond or Ar–N
bond or a concerted rotation (Table S15). Given the energy difference between the cis and trans conformations, it is not surprising to find that at
equilibrium, >99% of the scaffold exists in the folded conformation
at 298 K. However, this does not preclude the molecule from adopting
a trans conformation. The low energy barriers associated
with these bond rotations strongly suggests that our scaffold can
sample an extended “helix mimetic” conformation at room
temperature.We described the design, synthesis, and conformational
analysis
of a novel oligo 3-O, 4-N-dialkylated
benzanilide helix mimetic scaffold capable of simultaneous mimicry
of side chains i, i+2, i+4, i+6, i+7, and i+9 of a canonical α-helix. The synthetic route is the shortest
and most straightforward described to date for multifacial helix mimetics.
A combination of solid-state, solution-phase, and in silico analyses show that the helix mimetic scaffold rapidly samples a
wide variety of conformations in solution and can successfully mimic
the relevant helical pharmacophore. The increased conformational plasticity
in comparison with previous helix mimetic design is a shift for the
proteomimetic field. To this date, the analysis of helix mimetics
has focused on reporting RMSD values obtained from energy-minimized
or solid-state structures. As noted by Burgess, it is evident that
this is not representative of the equilibrating conformations present
in solution.[30−32] This work goes part way to demonstrating that a more
sophisticated approach to characterization of helix mimetics is required
if the values are to be considered a determinant in the quality of
a scaffold. Furthermore, a degree of conformational plasticity has
been noted to be advantageous for protein–surface recognition
through an induced-fit-type mechanism. This is even more pertinent
given that most secondary structure elements at protein interfaces
are perturbed from geometric ideality. Future work on this scaffold
will focus initially on inhibition of complex helix–protein
interactions that are mediated by the binding of more than one helical
face. For example, malaria parasite invasion of host red blood cells
is critically dependent on the fully buried interaction which exists
between myosin tail interacting protein (MTIP) and myosin A (MyoA),[33] and in oncology, the Wnt signaling pathway is
centered around β-catenin, which forms multifacial PPIs with
T-cell factor 4 (Tcf-4)[34] and B cell lymphoma
9 (BCL9).[35]
Authors: Kwan-Young Jung; Kenno Vanommeslaeghe; Maryanna E Lanning; Jeremy L Yap; Caryn Gordon; Paul T Wilder; Alexander D MacKerell; Steven Fletcher Journal: Org Lett Date: 2013-06-13 Impact factor: 6.005
Authors: Frederick Campbell; Jeffrey P Plante; Thomas A Edwards; Stuart L Warriner; Andrew J Wilson Journal: Org Biomol Chem Date: 2010-03-18 Impact factor: 3.876
Authors: Tom N Grossmann; Johannes T-H Yeh; Brian R Bowman; Qian Chu; Raymond E Moellering; Gregory L Verdine Journal: Proc Natl Acad Sci U S A Date: 2012-10-15 Impact factor: 11.205
Authors: Christopher H Douse; Sabrina J Maas; Jemima C Thomas; James A Garnett; Yunyun Sun; Ernesto Cota; Edward W Tate Journal: ACS Chem Biol Date: 2014-08-06 Impact factor: 5.100
Authors: Márton Zwillinger; Post Sai Reddy; Barbara Wicher; Pradeep K Mandal; Márton Csékei; Lucile Fischer; András Kotschy; Ivan Huc Journal: Chemistry Date: 2020-11-30 Impact factor: 5.236